Janux Therapeutics, Inc. (JANX) vs PROCEPT BioRobotics Corporation (PRCT)
A side-by-side comparison of Janux Therapeutics, Inc. and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JANX
Janux Therapeutics, Inc.
$16.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PRCT
PROCEPT BioRobotics Corporation
$17.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — JANX vs PRCT
growth of $100 · dividends reinvested · last 5yJANX -46.8% (-11.9%/yr)PRCT -57.5% (-15.7%/yr)JANX compounded faster over this window
JANX PRCT
JANX vs PRCT: by the numbers
- •JANX is the larger company ($1.02B vs $997M market cap).
- •Both run net losses; PRCT's is the smaller (-32.54% vs -321.81% net margin).
- •JANX grew revenue faster over the past five years (105.89% vs 74.27% CAGR).
Metrics side by side
Valuation
| Metric | JANX | PRCT |
|---|---|---|
| P/S ratio | 32.12 | 2.95 |
| P/B ratio | 1.10 | 2.93 |
Profitability
| Metric | JANX | PRCT |
|---|---|---|
| Gross margin | 79.71% | 63.74% |
| Operating margin | -1576.67% | -33.86% |
| Net margin | -321.81% | -32.54% |
| ROE | -11.06% | -32.27% |
| ROIC | -15.15% | -27.51% |
Growth (annualized)
| Metric | JANX | PRCT |
|---|---|---|
| Revenue CAGR (5Y) | 105.89% | 74.27% |
| Total return CAGR (5Y) | -6.45% | -14.36% |
Frequently asked
- Which has grown faster, JANX or PRCT?
- Over the past five years, JANX grew revenue faster — JANX at a 105.89% CAGR versus PRCT at 74.27%.
- How have JANX and PRCT total returns compared?
- Over the past 5 years, JANX delivered -6.45% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Janux Therapeutics ROEPROCEPT BioRobotics ROEJanux Therapeutics operating marginPROCEPT BioRobotics operating marginJanux Therapeutics revenue growthPROCEPT BioRobotics revenue growthJanux Therapeutics free cash flowPROCEPT BioRobotics free cash flow
Janux Therapeutics & PROCEPT BioRobotics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.